tetano
Editor, Senior Moderator
Pain Manag
. 2025 May 14:1-11.
doi: 10.1080/17581869.2025.2501521. Online ahead of print. Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions
Peter D Vu[SUP] 1 [/SUP], Salahadin Abdi[SUP] 2 [/SUP]
Affiliations
Purpose of review: Neuropathic pain is a recognized and debilitating symptom of SARS-CoV-2 infection across acute, post-acute, and long-COVID phases. Initially emerging as acute or subacute symptoms, these neuropathic manifestations can evolve into chronic conditions, with approximately 10% of all SARS-CoV-2 cases (estimated 65 million individuals globally) developing post-acute SARS-CoV-2 (PASC) neuropathic sequalae. Given the limited literature specifically addressing neuropathic pain related to PASC, a deeper understanding is needed to improve management and reduce patient burden.
Recent findings: PASC symptoms are associated with disease severity, elevated body mass indexes, preexisting psychological conditions, and addiction history. Sex differences appear to influence prevalence, and the multisystem nature of PASC complicates symptom presentation, with mood disorders, fatigue, and cognitive dysfunction contributing to altered pain perception. Proposed mechanisms include immune dysregulation, persistent viral protein effects, and neuroanatomical changes. Management typically involves a multimodal approach.
Summary: This review examines SARS-CoV-2 neuropathic pain across the illness trajectory, examining its pathophysiology, prevalence, and treatment. It highlights the potential for subacute neuropathic symptoms to become chronic and calls for future research to refine long-term management strategies and assess broader healthcare implications.
Keywords: PASC; Post-acute sequelae SARS-CoV-2 infection; coronavirus; long COVID; narrative review; neuropathic pain.
. 2025 May 14:1-11.
doi: 10.1080/17581869.2025.2501521. Online ahead of print. Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions
Peter D Vu[SUP] 1 [/SUP], Salahadin Abdi[SUP] 2 [/SUP]
Affiliations
- PMID: 40366711
- DOI: 10.1080/17581869.2025.2501521
Purpose of review: Neuropathic pain is a recognized and debilitating symptom of SARS-CoV-2 infection across acute, post-acute, and long-COVID phases. Initially emerging as acute or subacute symptoms, these neuropathic manifestations can evolve into chronic conditions, with approximately 10% of all SARS-CoV-2 cases (estimated 65 million individuals globally) developing post-acute SARS-CoV-2 (PASC) neuropathic sequalae. Given the limited literature specifically addressing neuropathic pain related to PASC, a deeper understanding is needed to improve management and reduce patient burden.
Recent findings: PASC symptoms are associated with disease severity, elevated body mass indexes, preexisting psychological conditions, and addiction history. Sex differences appear to influence prevalence, and the multisystem nature of PASC complicates symptom presentation, with mood disorders, fatigue, and cognitive dysfunction contributing to altered pain perception. Proposed mechanisms include immune dysregulation, persistent viral protein effects, and neuroanatomical changes. Management typically involves a multimodal approach.
Summary: This review examines SARS-CoV-2 neuropathic pain across the illness trajectory, examining its pathophysiology, prevalence, and treatment. It highlights the potential for subacute neuropathic symptoms to become chronic and calls for future research to refine long-term management strategies and assess broader healthcare implications.
Keywords: PASC; Post-acute sequelae SARS-CoV-2 infection; coronavirus; long COVID; narrative review; neuropathic pain.